Radiomedix, Inc.

Radiomedix, Inc.

Biotechnology Research

Houston, Texas 3,997 followers

Innovating Theranostics

About us

RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radio-pharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is commercializing generator-produced radio-pharmaceuticals based on Gallium-68 chemistry. RadioMedix is in late-stage development of a new radio-labeled analog targeting metabolic pathway, GlucoMedix, which is based on its patented DO2A-chelation technology. RadioMedix is introducing the SmartMedix™ automated laboratory system for synthesis of PET tracers for the research and clinical markets. RadioMedix has also established two service facilities for academic and industrial partners: cGMP Manufacturing Suite for clinical probe development and Molecular Imaging Facility for evaluation of agents in animal models.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Houston, Texas
Type
Privately Held
Founded
2006
Specialties
Innovative targeted radiopharmaceuticals, Biotechnology, Generator-produced radiopharmaceuticals based on Gallium-68, and Development of a new diagnostic and therapeutic radiolabeled agents

Locations

Employees at Radiomedix, Inc.

Updates

Affiliated pages

Similar pages

Browse jobs